CN105998956A - 一种治疗糖尿病的中药组合物 - Google Patents
一种治疗糖尿病的中药组合物 Download PDFInfo
- Publication number
- CN105998956A CN105998956A CN201610525006.XA CN201610525006A CN105998956A CN 105998956 A CN105998956 A CN 105998956A CN 201610525006 A CN201610525006 A CN 201610525006A CN 105998956 A CN105998956 A CN 105998956A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- rhizoma
- radix
- medicine composition
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 40
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 20
- 239000000203 mixture Substances 0.000 title claims abstract description 16
- 241000628997 Flos Species 0.000 claims abstract description 26
- 241000255791 Bombyx Species 0.000 claims abstract description 13
- 244000291333 Serissa japonica Species 0.000 claims abstract description 13
- 239000009636 Huang Qi Substances 0.000 claims description 22
- 241001057584 Myrrha Species 0.000 claims description 12
- 239000009286 sanguis draxonis Substances 0.000 claims description 12
- 239000002994 raw material Substances 0.000 claims description 11
- 241000282376 Panthera tigris Species 0.000 claims 3
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 claims 2
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 claims 2
- 235000021286 stilbenes Nutrition 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 13
- 238000011282 treatment Methods 0.000 abstract description 10
- 241001061264 Astragalus Species 0.000 abstract 2
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 abstract 2
- 235000006533 astragalus Nutrition 0.000 abstract 2
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 235000003713 Rhodiola rosea Nutrition 0.000 abstract 1
- 244000042430 Rhodiola rosea Species 0.000 abstract 1
- 241001221020 Smilax riparia Species 0.000 abstract 1
- 240000004824 Trimezia steyermarkii Species 0.000 abstract 1
- 239000009136 dragon's blood Substances 0.000 abstract 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 20
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 14
- 239000008103 glucose Substances 0.000 description 14
- 239000008280 blood Substances 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 13
- 102000004877 Insulin Human genes 0.000 description 10
- 108090001061 Insulin Proteins 0.000 description 10
- 229940125396 insulin Drugs 0.000 description 10
- 229940123208 Biguanide Drugs 0.000 description 8
- 150000004283 biguanides Chemical class 0.000 description 8
- 229940079593 drug Drugs 0.000 description 7
- 229940100389 Sulfonylurea Drugs 0.000 description 5
- 235000012054 meals Nutrition 0.000 description 5
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 4
- 235000001727 glucose Nutrition 0.000 description 4
- 201000001421 hyperglycemia Diseases 0.000 description 4
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 4
- 230000037396 body weight Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 238000002651 drug therapy Methods 0.000 description 3
- 230000003914 insulin secretion Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 208000001380 Diabetic Ketoacidosis Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- FAEKWTJYAYMJKF-QHCPKHFHSA-N GlucoNorm Chemical compound C1=C(C(O)=O)C(OCC)=CC(CC(=O)N[C@@H](CC(C)C)C=2C(=CC=CC=2)N2CCCCC2)=C1 FAEKWTJYAYMJKF-QHCPKHFHSA-N 0.000 description 2
- 206010023379 Ketoacidosis Diseases 0.000 description 2
- 208000007976 Ketosis Diseases 0.000 description 2
- 241000220317 Rosa Species 0.000 description 2
- 244000105017 Vicia sativa Species 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 229940127003 anti-diabetic drug Drugs 0.000 description 2
- 239000003472 antidiabetic agent Substances 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 208000023589 ischemic disease Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 229960002354 repaglinide Drugs 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- XUFXOAAUWZOOIT-SXARVLRPSA-N (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound O([C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O)N[C@@H]1[C@@H]([C@@H](O)[C@H](O)C(CO)=C1)O)C)[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O XUFXOAAUWZOOIT-SXARVLRPSA-N 0.000 description 1
- SWLAMJPTOQZTAE-UHFFFAOYSA-N 4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]benzoic acid Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(C(O)=O)C=C1 SWLAMJPTOQZTAE-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 229940077274 Alpha glucosidase inhibitor Drugs 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 229940122199 Insulin secretagogue Drugs 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- 208000006399 Premature Obstetric Labor Diseases 0.000 description 1
- 206010036600 Premature labour Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000035415 Reinfection Diseases 0.000 description 1
- 208000025371 Taste disease Diseases 0.000 description 1
- 208000031320 Teratogenesis Diseases 0.000 description 1
- FZNCGRZWXLXZSZ-CIQUZCHMSA-N Voglibose Chemical compound OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O FZNCGRZWXLXZSZ-CIQUZCHMSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000010399 Wasting Syndrome Diseases 0.000 description 1
- XLIJUKVKOIMPKW-BTVCFUMJSA-N [O].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O Chemical compound [O].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O XLIJUKVKOIMPKW-BTVCFUMJSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229960002632 acarbose Drugs 0.000 description 1
- XUFXOAAUWZOOIT-UHFFFAOYSA-N acarviostatin I01 Natural products OC1C(O)C(NC2C(C(O)C(O)C(CO)=C2)O)C(C)OC1OC(C(C1O)O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O XUFXOAAUWZOOIT-UHFFFAOYSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000003888 alpha glucosidase inhibitor Substances 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000001610 euglycemic effect Effects 0.000 description 1
- 238000009207 exercise therapy Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 150000002304 glucoses Chemical class 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 208000006443 lactic acidosis Diseases 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229950004994 meglitinide Drugs 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 235000019656 metallic taste Nutrition 0.000 description 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 1
- 229960003105 metformin Drugs 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 229960000698 nateglinide Drugs 0.000 description 1
- OELFLUMRDSZNSF-BRWVUGGUSA-N nateglinide Chemical compound C1C[C@@H](C(C)C)CC[C@@H]1C(=O)N[C@@H](C(O)=O)CC1=CC=CC=C1 OELFLUMRDSZNSF-BRWVUGGUSA-N 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 229940127017 oral antidiabetic Drugs 0.000 description 1
- 239000003538 oral antidiabetic agent Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- ICFJFFQQTFMIBG-UHFFFAOYSA-N phenformin Chemical compound NC(=N)NC(=N)NCCC1=CC=CC=C1 ICFJFFQQTFMIBG-UHFFFAOYSA-N 0.000 description 1
- 208000026440 premature labor Diseases 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 208000002254 stillbirth Diseases 0.000 description 1
- 231100000537 stillbirth Toxicity 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229960001729 voglibose Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Insects & Arthropods (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种治疗糖尿病的中药组合物,涉及中药技术领域。由下述重量配比的中药原料制成:白芨15‑20g,罗汉果15‑35g,白芷15‑25g,没药15‑25g,黄精20‑35g,煅自然铜10‑50g,虎杖20‑45g,黄芪35‑65g,槐米35‑55g,六月雪5‑35g,血竭15‑35g,双花15‑35g,牛尾菜20‑40g,僵蚕15‑35g,黄芪25‑45g,泽兰5‑10g、小果蔷薇10‑20g。本发明解决以往此类中药治疗中效果不够明显,见效比较迟缓的问题,效果好、见效快。
Description
技术领域
本发明涉及一种治疗糖尿病的中药组合物,涉及中药技术领域。
背景技术
糖尿病是一组以高血糖为特征的代谢性疾病。高血糖则是由于胰岛素分泌缺陷或其生物作用受损,或两者兼有引起。糖尿病时长期存在的高血糖,导致各种组织,特别是眼、肾、心脏、血管、神经的慢性损害、功能障碍。目前尚无根治糖尿病的方法,但通过多种治疗手段可以控制好糖尿病。主要包括5个方面:糖尿病患者的教育,自我监测血糖,饮食治疗,运动治疗和药物治疗。
磺脲类药物2型DM患者经饮食控制,运动,降低体重等治疗后,疗效尚不满意者均可用磺脲类药物。因降糖机制主要是刺激胰岛素分泌,所以对有一定胰岛功能者疗效较好。对一些发病年龄较轻,体形不胖的糖尿病患者在早期也有一定疗效。但对肥胖者使用磺脲类药物时,要特别注意饮食控制,使体重逐渐下降,与双胍类或α-葡萄糖苷酶抑制剂降糖药联用较好。下列情况属禁忌证:一是严重肝、肾功能不全;二是合并严重感染,创伤及大手术期间,临时改用胰岛素治疗;三是糖尿病酮症、酮症酸中毒期间,临时改用胰岛素治疗;四是糖尿病孕妇,妊娠高血糖对胎儿有致畸形作用,早产、死产发生率高,故应严格控制血糖,应把空腹血糖控制在105毫克/分升(5.8毫摩尔/升)以下,餐后2小时血糖控制在120毫克/分升(6.7毫摩尔/升)以下,但控制血糖不宜用口服降糖药;五是对磺脲类药物过敏或出现明显不良反应。
双胍类降糖药降血糖的主要机制是增加外周组织对葡萄糖的利用,增加葡萄糖的无氧酵解,减少胃肠道对葡萄糖的吸收,降低体重。①适应证肥胖型2型糖尿病,单用饮食治疗效果不满意者;2型糖尿病单用磺脲类药物效果不好,可加双胍类药物;1型糖尿病用胰岛素治疗病情不稳定,用双胍类药物可减少胰岛素剂量;2型糖尿病继发性失效改用胰岛素治疗时,可加用双胍类药物,能减少胰岛素用量。②禁忌证严重肝、肾、心、肺疾病,消耗性疾病,营养不良,缺氧性疾病;糖尿病酮症,酮症酸中毒;伴有严重感染、手术、创伤等应激状况时暂停双胍类药物,改用胰岛素治疗;妊娠期。③不良反应一是胃肠道反应。最常见、表现为恶心、呕吐、食欲下降、腹痛、腹泻,发生率可达20%。为避免这些不良反应,应在餐中、或餐后服药。二是头痛、头晕、金属味。三是乳酸酸中毒,多见于长期、大量应用降糖灵,伴有肝、肾功能减退,缺氧性疾病,急性感染、胃肠道疾病时,降糖片引起酸中毒的机会较少。
α葡萄糖苷酶抑制剂1型和2型糖尿病均可使用,可以与磺脲类,双胍类或胰岛素联用。①伏格列波糖餐前即刻口服。②阿卡波糖餐前即刻口服。主要不良反应有:腹痛、肠胀气、腹泻、***排气增多。
胰岛素增敏剂有增强胰岛素作用,改善糖代谢。可以单用,也可用磺脲类,双胍类或胰岛素联用。有肝脏病或心功能不全者者不宜应用。
格列奈类胰岛素促分泌剂①瑞格列奈为快速促胰岛素分泌剂,餐前即刻口服,每次主餐时服,不进餐不服。②那格列奈作用类似于瑞格列奈。
发明内容
本发明的目的在于针对现有技术的不足,提供一种治疗糖尿病的中药组合物,解决以往此类中药治疗中效果不够明显,见效比较迟缓的问题,效果好、见效快。
本发明得目的是通过以下技术方案实现的:
一种治疗糖尿病的中药组合物,由下述重量配比的中药原料制成:白芨15-20g,罗汉果15-35g,白芷15-25g,没药15-25g,黄精20-35g,煅自然铜10-50g,虎杖20-45g,黄芪35-65g,槐米35-55g,六月雪5-35g,血竭15-35g,双花15-35g,牛尾菜20-40g,僵蚕15-35g,黄芪25-45g,泽兰5-10g、小果蔷薇10-20g。
优选的,由下述重量配比的中药原料制成:白芨15g,罗汉果15g,白芷15g,没药15g,黄精20g,煅自然铜10g,虎杖20g,黄芪35g,槐米35g,六月雪5g,血竭15g,双花15g,牛尾菜20g,僵蚕15g,黄芪25g,泽兰5g、小果蔷薇10g。
优选的,由下述重量配比的中药原料制成:白芨20g,罗汉果35g,白芷25g,没药25g,黄精35g,煅自然铜50g,虎杖45g,黄芪65g,槐米55g,六月雪35g,血竭35g,双花35g,牛尾菜40g,僵蚕35g,黄芪45g,泽兰10g、小果蔷薇20g。
优选的,由下述重量配比的中药原料制成:白芨18g,罗汉果30g,白芷20g,没药20g,黄精30g,煅自然铜30g,虎杖40g,黄芪60g,槐米50g,六月雪30g,血竭30g,双花30g,牛尾菜30g,僵蚕30g,黄芪40g,泽兰8g、小果蔷薇18g。
本发明可以采用中药制剂的常规制备工艺,可制成任何一种药剂学上所说的剂型。例如可以将这些原料药研成粉末状混合均匀制成散剂冲服;可以用水煎,经过滤得滤液,加入防腐剂制成口服液;必要时也可以直接服用汤剂。
本发明药物具有益气养阴,活血通络,疗效确切,成本低廉,无毒副作用。
典型病例
(1)王某,女,52岁,血糖高6年,间断服用口服降糖药、测血糖8mmol/L,餐后血糖16mmol/L,服用本发明药物治疗,10天后,血糖正常。
(2)张某,男,60岁,糖尿病史11年,治疗不***,多自行购药,血糖未能达标多在10mmol/L以上,以往有高血压病8年,化验血糖13mmol,糖化红蛋白12%,服用本发明药物治疗,一个疗程后,血糖好转,两个疗程后,血糖正常。
(3)孙某,男,糖尿病早期患者,感觉双脚皮肤瘙痒、怕冷、感觉迟钝或丧失,血糖高,吸收不好。用本发明药物,5天后明显奏效,14天后,症状消失。
具体实施方式
下面结合实施例对本发明作进一步的描述:
本发明由以下重量份的原料药物配制而成:
白芨15-20g,罗汉果15-35g,白芷15-25g,没药15-25g,黄精20-35g,煅自然铜10-50g,虎杖20-45g,黄芪35-65g,槐米35-55g,六月雪5-35g,血竭15-35g,双花15-35g,牛尾菜20-40g,僵蚕15-35g,黄芪25-45g,泽兰5-10g、小果蔷薇10-20g。
实施例1
一种治疗糖尿病的中药组合物,由下述重量配比的中药原料制成:白芨15g,罗汉果15g,白芷15g,没药15g,黄精20g,煅自然铜10g,虎杖20g,黄芪35g,槐米35g,六月雪5g,血竭15g,双花15g,牛尾菜20g,僵蚕15g,黄芪25g,泽兰5g、小果蔷薇10g。
实施例2
一种治疗糖尿病的中药组合物,由下述重量配比的中药原料制成:白芨20g,罗汉果35g,白芷25g,没药25g,黄精35g,煅自然铜50g,虎杖45g,黄芪65g,槐米55g,六月雪35g,血竭35g,双花35g,牛尾菜40g,僵蚕35g,黄芪45g,泽兰10g、小果蔷薇20g。
实施例3
一种治疗糖尿病的中药组合物,由下述重量配比的中药原料制成:白芨18g,罗汉果30g,白芷20g,没药20g,黄精30g,煅自然铜30g,虎杖40g,黄芪60g,槐米50g,六月雪30g,血竭30g,双花30g,牛尾菜30g,僵蚕30g,黄芪40g,泽兰8g、小果蔷薇18g。
Claims (4)
1.一种治疗糖尿病的中药组合物,其特征在于,由下述重量配比的中药原料制成:白芨15-20g,罗汉果15-35g,白芷15-25g,没药15-25g,黄精20-35g,煅自然铜10-50g,虎杖20-45g,黄芪35-65g,槐米35-55g,六月雪5-35g,血竭15-35g,双花15-35g,牛尾菜20-40g,僵蚕15-35g,黄芪25-45g,泽兰5-10g、小果蔷薇10-20g。
2.根据权利要求1所述的一种治疗糖尿病的中药组合物,其特征在于,由下述重量配比的中药原料制成:白芨15g,罗汉果15g,白芷15g,没药15g,黄精20g,煅自然铜10g,虎杖20g,黄芪35g,槐米35g,六月雪5g,血竭15g,双花15g,牛尾菜20g,僵蚕15g,黄芪25g,泽兰5g、小果蔷薇10g。
3.根据权利要求1所述的一种治疗糖尿病的中药组合物,其特征在于,由下述重量配比的中药原料制成:白芨20g,罗汉果35g,白芷25g,没药25g,黄精35g,煅自然铜50g,虎杖45g,黄芪65g,槐米55g,六月雪35g,血竭35g,双花35g,牛尾菜40g,僵蚕35g,黄芪45g,泽兰10g、小果蔷薇20g。
4.根据权利要求1所述的一种治疗糖尿病的中药组合物,其特征在于,由下述重量配比的中药原料制成:白芨18g,罗汉果30g,白芷20g,没药20g,黄精30g,煅自然铜30g,虎杖40g,黄芪60g,槐米50g,六月雪30g,血竭30g,双花30g,牛尾菜30g,僵蚕30g,黄芪40g,泽兰8g、小果蔷薇18g。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610525006.XA CN105998956A (zh) | 2016-07-01 | 2016-07-01 | 一种治疗糖尿病的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610525006.XA CN105998956A (zh) | 2016-07-01 | 2016-07-01 | 一种治疗糖尿病的中药组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105998956A true CN105998956A (zh) | 2016-10-12 |
Family
ID=57106508
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610525006.XA Pending CN105998956A (zh) | 2016-07-01 | 2016-07-01 | 一种治疗糖尿病的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105998956A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107737241A (zh) * | 2017-11-25 | 2018-02-27 | 衡阳县华盛达农林科技有限公司 | 治疗糖尿病的槐米中药组合物及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103083531A (zh) * | 2011-10-27 | 2013-05-08 | 彭竹妍 | 治疗糖尿病的药物 |
CN103599411A (zh) * | 2013-11-19 | 2014-02-26 | 太和县中医院 | 一种治疗糖尿病的中药 |
CN103705842A (zh) * | 2013-12-04 | 2014-04-09 | 李兴华 | 一种治疗糖尿病的中药组合物 |
CN103721067A (zh) * | 2014-01-14 | 2014-04-16 | 王玉梅 | 一种糖尿病足护理中药组合物 |
CN104083674A (zh) * | 2014-07-19 | 2014-10-08 | 河南中医学院 | 一种治疗糖尿病肾病的灌肠中药液 |
-
2016
- 2016-07-01 CN CN201610525006.XA patent/CN105998956A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103083531A (zh) * | 2011-10-27 | 2013-05-08 | 彭竹妍 | 治疗糖尿病的药物 |
CN103599411A (zh) * | 2013-11-19 | 2014-02-26 | 太和县中医院 | 一种治疗糖尿病的中药 |
CN103705842A (zh) * | 2013-12-04 | 2014-04-09 | 李兴华 | 一种治疗糖尿病的中药组合物 |
CN103721067A (zh) * | 2014-01-14 | 2014-04-16 | 王玉梅 | 一种糖尿病足护理中药组合物 |
CN104083674A (zh) * | 2014-07-19 | 2014-10-08 | 河南中医学院 | 一种治疗糖尿病肾病的灌肠中药液 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107737241A (zh) * | 2017-11-25 | 2018-02-27 | 衡阳县华盛达农林科技有限公司 | 治疗糖尿病的槐米中药组合物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1148211C (zh) | 用于治疗充血性心力衰竭的药物 | |
CN102743540A (zh) | 联合降糖方 | |
CN104225441A (zh) | 一种治疗胃病的中药组合物及其颗粒剂和胶囊剂的制备方法 | |
CN102225139B (zh) | 一种陈术健脾膏及其制备方法 | |
CN103202879B (zh) | 一种治疗慢性心力衰竭的中药组合物及制备方法 | |
CN102949630A (zh) | 一种治疗胃肠动力不足引起腹胀的中药组合物 | |
CN104288412B (zh) | 一种治疗代谢综合征的中药组合物 | |
CN102114231B (zh) | 一种治疗心律失常的药物 | |
CN109528968A (zh) | 一种治疗2型糖尿病的中药组合物及其制备方法和应用 | |
CN105998956A (zh) | 一种治疗糖尿病的中药组合物 | |
CN102274396B (zh) | 治疗糖尿病肾病的中药及其制备方法 | |
CN101254266B (zh) | 一种治疗心脑血管疾病的药物 | |
CN103006980A (zh) | 一种治疗痞满的中药组合物 | |
CN106072556A (zh) | 用于调节血糖的保健食品及其制备方法 | |
CN102114185B (zh) | 一种治疗2型糖尿病胰岛素抵抗的药物 | |
CN105232754A (zh) | 一种用于治疗ⅱ型糖尿病的药物 | |
CN105267791A (zh) | 一种治疗痞满的中药复合物、其制备方法及应用 | |
CN103989940A (zh) | 一种治疗糖尿病的中药组合物 | |
CN106110127A (zh) | 一种用于肺结核的中药组合物 | |
CN105663772A (zh) | 一种治疗糖尿病的药物 | |
CN106822852A (zh) | 治疗冠心病的药物组合物、其制备工艺及用途 | |
CN106606744A (zh) | 一种用于治疗ⅱ型糖尿病的组合药物 | |
CN100423764C (zh) | 一种内服用于***的中药组合物 | |
CN104958684A (zh) | 一种治疗慢性胃炎的药物 | |
CN105412668A (zh) | 一种治疗糖尿病的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20161012 |
|
WD01 | Invention patent application deemed withdrawn after publication |